-transparent.png){kind=logo}
Numerous drugs have been suggested for the treatment of systemic scleroderma. They may be studied and classified according to their site of action on the chain of events that leads from vascular abnormalities to sclerosis of the skin. Thus, proline analogues, colchicine, lathyrogenic agents, D-penicillamine, coagulation factor XIII and oestrogens are thought to act on collagens and their metabolism. Ketanserin has been suggested by the discovery of tryptophan abnormalities. Corticosteroids exert an inhibitory effect on fibroblasts. The use of calcium antagonists, angiotensin-converting enzyme inhibitors, prostacyclin and anti-platelets rests on the presence of vascular abnormalities. The purpose of treatments with immunosuppressive drugs or plasma exchanges is to act on possible lymphocytic and/or macropageal factors.
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
April 1980,
Revue medicale de Liege,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
January 1956,
Anales. Universidad Nacional Mayor de San Marcos. Facultad de Medicina,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
January 1980,
Revista espanola de reumatismo y enfermedades osteoarticulares,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
January 1953,
El Dia medico,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
March 1971,
Laval medical,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
March 1953,
Arquivos brasileiros de cardiologia,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
February 1971,
Acta gastro-enterologica Belgica,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
October 1982,
Soins; la revue de reference infirmiere,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
January 1970,
Acquisitions medicales recentes,
O Blétry, and
C Francès, and
J Cadranel, and
P Godeau
January 2001,
Presse medicale (Paris, France : 1983),
